Example: Heart Attack

Clinical Trials Sponsored by Targeted Genetics Corporation

Total 6 results

    • NCT00617032
      Completed
      Phase 1 Dose Escalation Study of Intra-Articular Administration of tgAAC94
      Conditions: Rheumatoid Arthritis
    • NCT00126724
      Completed
      Study of Intra-articular Delivery of tgAAC94 in Inflammatory Arthritis Subjects
      Conditions: Arthritis, Rheumatoid; Arthritis, Psoriatic; Ankylosing Spondylitis
    • NCT00073463
      Terminated
      Safety and Efficacy of Recombinant Adeno-Associated Virus Containing the CFTR Gene in the Treatment of Cystic Fibrosis
      Conditions: Cystic Fibrosis
    • NCT00888446
      Completed
      Safety and Immunogenicity Study of tgAAC09, an HIV Vaccine in an Adeno-associated Virus (AAV) Capsid
      Conditions: Human Immunodeficiency Virus Infections; HIV Infections
    • NCT00643747
      Completed
      Safety Study of RPE65 Gene Therapy to Treat Leber Congenital Amaurosis
      Conditions: Retinal Degeneration
    • NCT00482027
      Completed
      Safety and Immunogenicity Study of tgAAC09, a Gag-PR-RT AAV HIV Vaccine
      Conditions: HIV Infection
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations